Dinghang Capital logo

Dinghang Capital

Asia, Jilin, China, Guangdong

Description

Dinghang Capital provides investors with professional asset management services.

Investor Profile

Dinghang Capital has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Seed (50%)

Country Focus

  • China (100%)

Industry Focus

  • Medical
  • Biotechnology
  • Health Care
  • Life Science
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Dinghang Capital frequently co-invest with?

CITIC Securities
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
BGI Co-Win
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Cornerstone Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Huasheng Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CPE Capital
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Green Pine Capital Partners
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Guofang Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Huatai Zijin Investment
Asia, Jiangsu, China, Nanjing
Co-Investments: 1
Titanium Capital
North America, Florida, United States, North Palm Beach
Co-Investments: 1

What are some of recent deals done by Dinghang Capital?

META Pharmaceuticals

Shenzhen, Guangdong, China

META Pharmaceuticals is a cutting-edge drug development company specializing in autoimmune diseases.

MedicalPharmaceutical
SeedJun 13, 2022
Amount Raised: $15,000,000
MGI Tech

Shenzhen, Guangdong, China

MGI Tech focuses on developing and promoting advanced life science tools for future healthcare.

BiotechnologyHealth CareLife ScienceMedical
Series BMay 28, 2020
Amount Raised: $1,000,000,000